BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 28501096)

  • 1. Combined diffusion-weighted imaging and dynamic contrast-enhanced MRI for differentiating radiologically indeterminate malignant from benign orbital masses.
    Xu XQ; Qian W; Ma G; Hu H; Su GY; Liu H; Shi HB; Wu FY
    Clin Radiol; 2017 Oct; 72(10):903.e9-903.e15. PubMed ID: 28501096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric approach with diffusion-weighted imaging and dynamic contrast-enhanced MRI: a comparison study for differentiating between benign and malignant bone lesions in adults.
    Oh E; Yoon YC; Kim JH; Kim K
    Clin Radiol; 2017 Jul; 72(7):552-559. PubMed ID: 28325514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of the response of ocular adnexal lymphoma to chemotherapy using combined pretreatment dynamic contrast-enhanced and diffusion-weighted MRI.
    Guo P; Liu Z; Yan F; Wang J; Wei L; Lv H; Wang Z; Xian J
    Acta Radiol; 2016 Dec; 57(12):1490-1496. PubMed ID: 27012277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation between orbital malignant and benign tumors using intravoxel incoherent motion diffusion-weighted imaging: Correlation with dynamic contrast-enhanced magnetic resonance imaging.
    Xu XQ; Hu H; Su GY; Liu H; Wu FY; Shi HB
    Medicine (Baltimore); 2019 Mar; 98(12):e14897. PubMed ID: 30896639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of orbital masses by multiparametric MRI.
    Ro SR; Asbach P; Siebert E; Bertelmann E; Hamm B; Erb-Eigner K
    Eur J Radiol; 2016 Feb; 85(2):324-36. PubMed ID: 26781137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diffusion weighted imaging and perfusion weighted imaging in the differential diagnosis of benign and malignant renal masses on 3.0 T MRI].
    Xu X; Wang P; Ma L; Shao Z; Zhang M
    Zhonghua Yi Xue Za Zhi; 2015 Jan; 95(3):200-4. PubMed ID: 25877031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orbital benign and malignant lymphoproliferative disorders: Differentiation using semi-quantitative and quantitative analysis of dynamic contrast-enhanced magnetic resonance imaging.
    Hu H; Xu XQ; Liu H; Hong XN; Shi HB; Wu FY
    Eur J Radiol; 2017 Mar; 88():88-94. PubMed ID: 28189215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Resolution Diffusion-Weighted Imaging Improves the Diagnostic Accuracy of Dynamic Contrast-Enhanced Sinonasal Magnetic Resonance Imaging.
    Wang F; Sha Y; Zhao M; Wan H; Zhang F; Cheng Y; Tang W
    J Comput Assist Tomogr; 2017; 41(2):199-205. PubMed ID: 27560026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DCE-MR imaging of orbital lesions: diagnostic performance of the tumor flow residence time τ calculated by a multi-compartmental pharmacokinetic tumor model based on individual factors.
    Erb-Eigner K; Asbach P; Ro SR; Haas M; Bertelmann E; Pietsch H; Schwenke C; Taupitz M; Denecke T; Hamm B; Lawaczeck R
    Acta Radiol; 2019 May; 60(5):643-652. PubMed ID: 30114927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors.
    Choi YJ; Lee IS; Song YS; Kim JI; Choi KU; Song JW
    J Magn Reson Imaging; 2019 Sep; 50(3):798-809. PubMed ID: 30663160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign and malignant orbital lymphoproliferative disorders: Differentiating using multiparametric MRI at 3.0T.
    Xu XQ; Hu H; Liu H; Wu JF; Cao P; Shi HB; Wu FY
    J Magn Reson Imaging; 2017 Jan; 45(1):167-176. PubMed ID: 27299917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative dynamic contrast-enhanced and diffusion-weighted MRI for differentiation between nasopharyngeal carcinoma and lymphoma at the primary site.
    Yu XP; Hou J; Li FP; Xiang W; Lu Q; Hu Y; Wang H
    Dentomaxillofac Radiol; 2016; 45(3):20150317. PubMed ID: 26846711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intravoxel incoherent motion diffusion-weighted MR imaging with dynamic contrast-enhanced MRI for differentiating lung cancer from benign solitary pulmonary lesions.
    Yuan M; Zhang YD; Zhu C; Yu TF; Shi HB; Shi ZF; Li H; Wu JF
    J Magn Reson Imaging; 2016 Mar; 43(3):669-79. PubMed ID: 26340144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion Weighted Imaging for Differentiating Benign from Malignant Orbital Tumors: Diagnostic Performance of the Apparent Diffusion Coefficient Based on Region of Interest Selection Method.
    Xu XQ; Hu H; Su GY; Liu H; Shi HB; Wu FY
    Korean J Radiol; 2016; 17(5):650-6. PubMed ID: 27587953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
    Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
    World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.
    Li X; Abramson RG; Arlinghaus LR; Kang H; Chakravarthy AB; Abramson VG; Farley J; Mayer IA; Kelley MC; Meszoely IM; Means-Powell J; Grau AM; Sanders M; Yankeelov TE
    Invest Radiol; 2015 Apr; 50(4):195-204. PubMed ID: 25360603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contrast-enhanced MRI in orbital lymphoproliferative disorders: Effects of region of interest selection methods on time efficiency, measurement reproducibility, and diagnostic ability.
    Qian W; Xu XQ; Hu H; Su GY; Wu JF; Shi HB; Wu FY
    J Magn Reson Imaging; 2018 May; 47(5):1298-1305. PubMed ID: 28922524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of quantitative multiparametric MRI in differentiating pleomorphic adenomas from malignant epithelial tumors in lacrimal gland.
    Wang Y; Song L; Guo J; Xian J
    Neuroradiology; 2020 Sep; 62(9):1141-1147. PubMed ID: 32430642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
    Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
    Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.